Advertisement
IMVT vs ORKA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Hold and ORKA is a Hold.
IMVT in downward trend: 10-day moving average crossed below 50-day moving average on September 10, 2026
The 10-day moving average for IMVT crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for IMVT entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
Following a +0.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMVT advanced for three days, in 207 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
IMVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.407) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. IMVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 63 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
ORKA in downward trend: price dove below 50-day moving average on September 18, 2026
ORKA moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend. In 38 of 48 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 79%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORKA as a result. In 65 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for ORKA turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 37 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORKA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for ORKA entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for ORKA's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +1.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORKA advanced for three days, in 203 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
ORKA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.015) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. ORKA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORKA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
IMVT | ORKA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 58 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 51 Fair valued | 39 Fair valued | |
PROFIT vs RISK RATING 1..100 | 63 | 100 | |
SMR RATING 1..100 | 98 | 94 | |
PRICE GROWTH RATING 1..100 | 63 | 39 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ORKA's Valuation (39) in the null industry is in the same range as IMVT (51). This means that ORKA’s stock grew similarly to IMVT’s over the last 12 months.
IMVT's Profit vs Risk Rating (63) in the null industry is somewhat better than the same rating for ORKA (100). This means that IMVT’s stock grew somewhat faster than ORKA’s over the last 12 months.
ORKA's SMR Rating (94) in the null industry is in the same range as IMVT (98). This means that ORKA’s stock grew similarly to IMVT’s over the last 12 months.
ORKA's Price Growth Rating (39) in the null industry is in the same range as IMVT (63). This means that ORKA’s stock grew similarly to IMVT’s over the last 12 months.
ORKA's P/E Growth Rating (100) in the null industry is in the same range as IMVT (100). This means that ORKA’s stock grew similarly to IMVT’s over the last 12 months.
| IMVT | ORKA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 79% | 1 day ago 77% |
| Stochastic ODDS (%) | N/A | 1 day ago 72% |
| Momentum ODDS (%) | N/A | 1 day ago 68% |
| MACD ODDS (%) | N/A | 1 day ago 69% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 73% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 71% |
| Advances ODDS (%) | 25 days ago 77% | 15 days ago 79% |
| Declines ODDS (%) | 1 day ago 81% | 1 day ago 74% |
| BollingerBands ODDS (%) | 1 day ago 76% | 1 day ago 60% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 73% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IMVT’s FA Score shows that 0 FA rating(s) are green while ORKA’s FA Score has 0 green FA rating(s).
- IMVT’s FA Score: 0 green, 5 red.
- ORKA’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IMVT’s TA Score shows that 3 TA indicator(s) are bullish while ORKA’s TA Score has 4 bullish TA indicator(s).
- IMVT’s TA Score: 3 bullish, 3 bearish.
- ORKA’s TA Score: 4 bullish, 5 bearish.
Price Growth
IMVT (@Biotechnology) experienced а -9.09% price change this week, while ORKA (@Biotechnology) price change was -4.41% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -5.57%. For the same industry, the average monthly price growth was -12.13%, and the average quarterly price growth was -18.10%.
Reported Earning Dates
IMVT is expected to report earnings on Nov 18, 2026.
ORKA is expected to report earnings on Nov 18, 2026.
Industries' Descriptions
@Biotechnology (-5.57% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PALL | 20.58 | 0.75 | +3.78% |
| abrdn Physical Palladium Shares ETF (PALL) | |||
| PLTM | 15.61 | 0.26 | +1.69% |
| GraniteShares Platinum Trust (PLTM) | |||
| MCHI | 51.69 | 0.25 | +0.49% |
| iShares MSCI China ETF (MCHI) | |||
| ARCM | 100.07 | 0.04 | +0.03% |
| Arrow Reserve Capital Management ETF (ARCM) | |||
| YFYA | 9.69 | -0.01 | -0.10% |
| Yields for You Strategy A ETF | |||
IMVT and
Correlation & Price change
A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.
| Ticker / NAME | Correlation To IMVT | 1D Price Change % | ||
|---|---|---|---|---|
| IMVT | 100% | -1.40% | ||
| ROIV - IMVT | 63% Loosely correlated | +1.25% | ||
| KURA - IMVT | 53% Loosely correlated | +0.94% | ||
| LXEO - IMVT | 45% Loosely correlated | +4.94% | ||
| DYN - IMVT | 44% Loosely correlated | +1.66% | ||
| SYRE - IMVT | 44% Loosely correlated | +1.87% | ||
More | ||||
ORKA and
Correlation & Price change
A.I.dvisor indicates that over the last year, ORKA has been loosely correlated with SYRE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ORKA jumps, then SYRE could also see price increases.
| Ticker / NAME | Correlation To ORKA | 1D Price Change % | ||
|---|---|---|---|---|
| ORKA | 100% | -3.66% | ||
| SYRE - ORKA | 51% Loosely correlated | +1.87% | ||
| DNTH - ORKA | 43% Loosely correlated | -0.31% | ||
| CGON - ORKA | 41% Loosely correlated | +0.03% | ||
| IMVT - ORKA | 41% Loosely correlated | -1.40% | ||
| TRVI - ORKA | 41% Loosely correlated | +0.41% | ||
More | ||||